Treatment of dry, age-related macular degeneration by epidermal growth factor
Phase 2
- Conditions
- on-exudative age-related macular degenerationEye Diseases
- Registration Number
- ISRCTN12733334
- Lead Sponsor
- fa Eye Research Institute
- Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34261661/ (added 16/07/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
1. Age of 50 + years
2. Pseudophakia
3. Presence of geographic atrophy
4. Normal intraocular pressure
5. Lack of any other ocular disease except for age-related macular degeneration, and absence of any malignancy
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method